Stocks to Watch: Chelsea Therapeutics International Ltd. (NASDAQ:CHTP), Versar Inc. (NYSEMKT:VSR)

167

Chelsea Therapeutics International LtdChelsea Therapeutics International Ltd. (NASDAQ:CHTP) issues statement regarding postponement of NORTHERA NDA PDUFA action date due to severe weather. Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) issues the following statement regarding the FDA Prescription Drug User Fee Act action date for the Company’s NORTHERA New Drug Application:

“As a result of severe weather conditions leading to an office closure, FDA today notified Chelsea Therapeutics that the goal date for the Company’s NORTHERA NDA has been extended to the next business day, or Tuesday, February 18, 2014.”

Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) shares rose 5.71% in current session and trading at $5.01. Chelsea Therapeutics International Ltd’s 52 week range is $0.76 – $5.78.

Versar Inc. (NYSEMKT:VSR) announces the extension of exchange offers and consent solicitations. Versar Inc. (NYSEMKT:VSR) announces that two of its wholly owned subsidiaries, Verso Paper Holdings and Verso Paper have extended the expiration date for their previously announced exchange offers and consent solicitations with respect to their outstanding 8.75% Second Priority Senior Secured Notes due 2019 and 11 3/8% Senior Subordinated Notes due 2016 from 5:00 p.m., New York City time, on Friday, February 14, 2014, to 5:00 p.m., New York City time, on Thursday, February 20, 2014, unless further extended. Versar Inc. (NYSEMKT:VSR) shares fell -0.26% in current session and trading at $3.87. Versar Inc’s 52 weeks range is $3.69 – $5.65.

Comments